Cryolife

Medical Management Associates (MMA), established in 1982, specializes in providing comprehensive management resources tailored for physicians and related healthcare organizations. Their seasoned consultants are equipped with extensive experience in healthcare management consulting and valuation, offering services that enhance business performance and strategic decision-making. With a diverse range of core competencies, MMA focuses on areas such as practice management, valuation services, and regulatory compliance, while also addressing the needs of practice start-ups, mergers, and acquisitions. Their team combines a profound understanding of healthcare economics with a sophisticated approach to medical practice management, ensuring a supportive partnership for their clients. Generated from the website

Established in 2006, MiMedx Group designs and develops biomaterial-based products for use in musculoskeletal specialties. The company offers biomaterials to treat a range of acute and chronic diseases and disorders. It serves the health care pharmaceutical markets in Europe, Asia, North America and South America. MiMedx Group utilizes several scientific technologies to develop medical instrumentation and surgical techniques. The company specializes in the commercialization of medical device technologies for application in spine and chronic back pain treatments. It provides products to repair a variety of soft tissues, such as tendons, ligaments and cartilage. In addition, the company offers ongoing product development programs. MiMedx Group is licensed by the University of South Florida Research Foundation for nordihydroguaiaretic acid technologies.

UCB Pharma is one of many wholly-owned subsidiaries of UCB S.A., a biopharmaceutical leader specializing in fields of central nervous system disorders, allergy and respiratory diseases, immune and inflammatory disorders and oncology. The company s main products include Keppra, Xyzal, Nootropil, Atarax, Lortab, Tussionex, Metadate CD, Equasym XL and Dipentum. The company directs profits from the sale and distribution of its products toward further research in its many fields. UCB Pharma s parent company maintains numerous additional facilities worldwide. The company recently acquired Celltech Group, helping form one of the world s largest biopharmaceutical companies. UCB was founded in 1928 by Emmanuel Janssen, a far-sighted Belgian businessman. UCB Pharma maintains its headquarters in Smyrna, Ga.